FIELD: medicine. SUBSTANCE: method involves measuring low density lipoproteins(LDLP), very low density lipoproteins(VLDLP), high density lipoproteins(HDLP) and cholesterol (ChS) contents in blood serum and lipid peroxidation products chemiluminescence ChL. Total photosum is determined in 60 s in kPhoton units. Diagnosis coefficient is calculated from a formula k= ChL(LDLP + VLDLP)x ChS(LDLP + VLDLP)/ ChL(HDLP) ChS(HDLP), where ChL(LDLP + VLDLP) and ChL(HDLP) are the total sum of chemiluminescence during 60 s caused by (LDLP + VLDLP) and (HDLP) fractions, respectively and ChL(LDLP + VLDLP) and ChL(HDLP) are cholesterol levels of the corresponding fractions. The diagnosis coefficient k being greater than 3.0, pathological pattern of climax period is diagnosed. EFFECT: simplified diagnosis method. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD EVALUATING EFFICIENCY OF MEDICAL TREATMENT OF ORTHOPEDIC-TRAUMATIC PATIENTS | 2001 |
|
RU2208788C2 |
| METHOD FOR DIAGNOSING AND PREDICTING CARDIAC ISCHEMIA DISEASE | 1999 |
|
RU2173853C2 |
| METHOD OF SYNTHESIS OF GAMMA-L-GLUTAMYLHISTAMINE, USE OF GAMMA-L-GLUTAMYLHISTAMINE, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2141968C1 |
| METHOD OF LIPID METABOLIC DISORDER CORRECTION | 2007 |
|
RU2337696C1 |
| METHOD OF PREDICTING RISK OF ADAPTATION FAILURE IN PEOPLE WORKING IN UNFAVORABLE CLIMATIC CONDITIONS OF ARCTIC | 2023 |
|
RU2810808C1 |
| METHOD FOR PREDICTING CLINICAL BEHAVIOR OF CARDIAC ISCHEMIA DISEASE | 2001 |
|
RU2228534C2 |
| METHOD FOR DETERMINING SEVERITY OF HYPOKINESIA IN FORMER ATHLETES | 2024 |
|
RU2835326C1 |
| METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
| METHOD FOR PREVENTING DYSLIPIDEMIA IN CHILDREN | 1995 |
|
RU2121329C1 |
| PROCEDURE EVALUATING SERIOUSNESS OF CONDITION OF TRAUMATIC PATIENT | 2001 |
|
RU2208787C2 |
